Kaplan Fox & Kilsheimer LLP said on Aug. 21, 2026, that it is investigating potential securities violations involving Alignment Healthcare, Inc. (NASDAQ: ALHC) after a former company executive filed a whistleblower complaint alleging accounting irregularities. The complaint said previously reported and projected results were artificially inflated, including Adjusted EBITDA, a non-GAAP measure used in financial reporting and executive compensation. It further alleged that millions of dollars in operating expenses were systematically misclassified as capital expenditures. After the allegations emerged on July 8, 2026, Alignment Healthcare shares fell $4.02, or 16.7%, to close at $20.03. Kaplan Fox is seeking information from investors who suffered losses or may assist its investigation. The press release also describes the firm's litigation history, including more than $10 billion recovered for clients and represented classes, and notes that contacting the firm does not create an attorney-client relationship or obligate it to retain a person as a client.